Terms & Policies
|
Site Map
|
Version francaise
Seventure
Success stories
Team
Portfolio
News
Contact
About us
Information and Communication Technologies
Life Sciences
Natixis
Information and Communication Technologies
Life Sciences
Information and Communication Technologies
Life Sciences
Join a start-up
Contact Seventure
Links
Industrial Biotech & Cleantech
Biopharmaceuticals
Medical Devices - Imaging and Diagnostics
Medical Devices - Implants & Surgical Solutions
Nutrition
Quality of Life (Products & Services)
Argen-x (NL)
Bioalliance Pharma
Enterome
Noxxon Pharma (DE)
OPi (EUSA Pharma)
Santaris Pharma (DK)
Syntaxin (UK)
Txcell
Syntaxin
www.syntaxin.com
Innovative medicines derived from botulinum toxin
D
evelopment of innovative drugs for acromegaly, pain and post-operative immobilization on the basis of a proprietary protein engineering platform dedicated to botulinum toxin.
News :
Syntaxin And Ipsen Enter Into...
10/21/2011
Syntaxin and Ipsen enter into a strategic agreement to develop novel botulinum-toxin...
Read more
PDF File
©Copyright SEVENTURE PARTNERS 2012